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Abstract
Loss of integrity and massive disruption of elastic fibers are key features of abdominal aortic 
aneurysm (AAA). Peroxisome proliferator-activated receptor γ (PPARγ) has been shown to 
attenuate AAA through inhibition of inflammation and proteolytic degradation. However, its 
involvement in elastogenesis during AAA remains unclear. PPARγ was highly expressed in human 
AAA within all vascular cells, including inflammatory cells and fibroblasts. In the aortas of 
transgenic mice expressing PPARγ at 25% normal levels (PpargC/− mice), we observed the 
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fragmentation of elastic fibers and reduced expression of vital elastic fiber components of elastin 
and fibulin-5. These were not observed in mice with 50% normal PPARγ expression (Pparg+/− 
mice). Infusion of a moderate dose of angiotensin II (AngII) (500 ng/kg/min) did not induce AAA 
but Pparg+/− aorta developed flattened elastic lamellae, while PpargC/− aorta showed severe 
destruction of elastic fibers. After infusion of AngII at 1000 ng/kg/min, 73% of PpargC/− mice 
developed atypical suprarenal aortic aneurysms: superior mesenteric arteries were dilated with 
extensive collagen deposition in adventitia and infiltrations of inflammatory cells. Although matrix 
metalloproteinase inhibition by doxycycline somewhat attenuated the dilation of aneurysm, it did 
not reduce the incidence nor elastic lamella deterioration in AngII-infused PpargC/− mice. 
Furthermore, PPARγ antagonism down-regulated elastin and fibulin-5 in fibroblasts, but not in 
vascular smooth muscle cells. Chromatin immunoprecipitation assay demonstrated PPARγ binding 
in the genomic sequence of fibulin-5 in fibroblasts. Our results underscore the importance of 
PPARγ in AAA development though orchestrating proper elastogenesis and preserving elastic 
fiber integrity.
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Introduction
While open surgical or endovascular repair procedures have reduced the mortality of 
ruptured abdominal aortic aneurysm (AAA) in the past decade,1 no effective 
pharmacological treatment has been conducted to inhibit the progression and rupture of 
human AAAs. Although medical management for hypertension and hyperlipidemia reveals 
potential benefits for lowering the growth rate of AAA,2 directly targeting vessel health is 
urgently needed. To this end, factors and cell types that are involved in the development of 
aneurysm need revisited.
Loss of integrity and massive disruption of elastic architecture are key features of structural 
changes in AAA.3 Elastic fiber is formed by initial synthesis of soluble precursor 
tropoelastin and later maturation by crosslinking of fibulins (fibulin-4 and fibulin-5) and 
fibrillins (fibrillin-1 and fibrillin-2) scaffold with the elastin core.4 In contrast, extensive 
infiltration of macrophages and lymphocytes increases the local expression of pro-
inflammatory cytokines and triggers production of elastolytic proteases. Elastic fibers are 
degraded by matrix metalloproteinases (MMP-2, MMP-9, MMP-7 and MMP-12) and 
cysteine proteinases (cathepsin S and cathepsin K).5 Aortic fibroblasts in AAA have not 
been well discussed, but they are documented within the media and adventitia of aneurysm, 
and express higher levels of several collagens and elastin.6 Thus, aortic fibroblasts may 
actively participate in elastic fiber turnover particularly when vascular smooth muscle cells 
(VSMCs) and elastic fiber components are compromised in AAA.
PPARγ has been shown to protect from vascular diseases through its anti-inflammatory 
effect. PPARγ activation in inflammatory cells reduces production of TNF-α, IL-1β and 
IL-6.7 PPARγ activation in VSMCs suppresses MMP-9 expression and collagen over-
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production.8, 9 Treatment with PPARγ agonists protects aorta against nicotine-induced 
calcification and elastic fiber fragmentation,10 and reduces the development and rupture of 
AngII-induced AAA.11 On the other hand, loss of PPARγ in VSMCs promotes aortic 
dilatation and elastin degradation in CaCl2-induced AAA.12 While these findings indicate a 
critical role of PPARγ in reduction of inflammation and elastic fiber degradation in AAA, 
several questions remain unsolved. First, the role of PPARγ in elastic fiber component 
production remains unclear. Second, the involvement of adventitial fibroblasts in PPARγ 
protective effect is lacking. Third, although PPARγ gene polymorphism is associated with 
the incidence and growth of AAA,13 the threshold levels of PPARγ to maintain integrity and 
prevent from AAA are not known.
In this study, we have tested our hypothesis that PPARγ plays key roles in maintenance of 
the elastic fiber integrity and prevention of AAA in response to exogenous stimuli, such as 
increased AngII. We took advantage of mice genetically altered to have different levels of 
PPARγ expression from 25% to 100%, and unveiled that fibroblasts express high levels of 
PPARγ in AAA and directly contribute to increased elastogenesis. When infused with AngII, 
mice with 25% PPARγ expression develop severely dilated suprarenal aneurysms involving 
roots of celiac artery (CA) and superior mesenteric artery (SMA). Our data underscore the 
importance of PPARγ in orchestrating proper elastogenesis and preserving elastic fiber 
integrity during AAA development.
Methods
Expanded Materials and Methods are available in the online-only Data Supplement.
Human Tissue Procurement
Human AAA samples were collected during open surgical repair of AAA. Samples from 
two patients were used for immunohistochemical staining. The specificity of primary 
antibody was confirmed by negative control procedures which gave consistently negative 
results (Figure S1). One patient had hypertension and the other had diabetes mellitus, and 
the diameters of infrarenal AAAs were 7.4 cm and 8 cm, respectively. Sections of normal 
human aorta, purchased from Origene, were obtained from a 57-year-old male with heart 
valve disorder. Sample diagnosis from pathology verification was non-tumor structures and 
within normal limits. The use of human samples was approved by the Institutional Review 
Board of National Cheng Kung University Hospital.
Mice
Experimental mice were F1 littermates from the mating of PpargC/+ mice on a C57BL/6J 
background with Pparg+/− mice on a 129S6 background.14 Two to three-month-old male 
Pparg+/+, Pparg+/− and PpargC/− littermates were used in all experiments. The following 
groups were studied: (1) No AngII infusion in Pparg+/+, Pparg+/− and PpargC/− mice, (2) 
AngII (500 ng/kg/min) infusion in Pparg+/+, Pparg+/− and PpargC/− mice, (3) AngII (1000 
ng/kg/min) infusion in Pparg+/+, Pparg+/− and PpargC/− mice, (4) AngII (1000 ng/kg/min) 
infusion + doxycycline (30 mg/kg/day) administration in PpargC/− mice. All animal studies 
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were performed according to protocols approved by the Institutional Animal Care and Use 
Committee of National Cheng Kung University.
Morphological Analysis of Aorta
The elastic fiber network was evaluated in the paraffin-embedded aortic section (5 μm) with 
Verhoeff’s stain (Sigma-Aldrich). Thickness of elastic lamella was measured by ImageJ 
software (NIH), and the average was based on > 24 randomly selected elastic lamellae from 
6 different cross-sectional fields per aorta. Waviness of elastic lamellae was graded on a 
scale from 1 to 5 in eight to ten non-overlapping fields of medial section: 1 (<20% of the 
waviness of a normal lamella), 2 (20~40% waviness), 3 (40~60% waviness), 4 (60~80% 
waviness), and 5 (>80% waviness); and the average of waviness score was presented.
Severity Grading of Aneurysm
The severity grading of mouse AAA was adapted according to the classification by 
Daugherty et al.15 We defined our severity grading of AAA by the pronounced form and its 
covered area of the aorta. Severity of aneurysm was graded on a scale from 0 to 4: 0 (no 
dilation in suprarenal aorta), 1 (dilation only in suprarenal aorta), 2 (dilation of suprarenal 
aneurysm that contains the root of CA and SMA), 3 (pronounced dilated aneurysm from 
suprarenal AA to SMA), 4 (rupture of aorta or death).
Data Analysis
Values are reported as mean ± SEM. Statistical analyses were conducted by Student’s t-test, 
one-way ANOVA followed by Tukey HSD multiple comparison test, or two-way ANOVA 
with treatment and genotype as factors. Differences were considered to be statistically 
significant at P <0.05.
Results
Upregulation of PPARγ in both Human and Mouse AAA
To evaluate the involvement of PPARγ in AAA, we first determined the expression of 
PPARγ in human AAA by immunohistochemistry. Normal human aortic samples scarcely 
expressed PPARγ (Figure 1A~B). Some PPARγ-positive cells with a high nuclear-
cytoplasmic ratio were present in the adventitia (Figure 1C). In human AAA sections, the 
intima was thickened with typical atherosclerotic changes, while media was significantly 
thinned. PPARγ expression was markedly increased within the atheroma under the fibrous 
caps as well as deeper near the media (Figure 1D). Within the media of aneurysm, PPARγ 
was increased in elongated cells with tapering ends, the characteristics of VSMCs (Figure 
1E). Within the adventitia of aneurysm, PPARγ was expressed markedly in cells with a high 
nuclear-cytoplasmic ratio with the characteristics of inflammatory cells (black arrows, 
Figure 1F). The bulk of inflammatory cells with high nuclear-cytoplasmic ratio in AAA have 
been reported as CD3+ T lymphocytes and CD19+ B lymphocytes.16 Consistently, only a 
small portion of inflammatory cells was positive for CD68 staining (Figure S2). PPARγ was 
also expressed in endothelial cells associated with vasa vasorum, and occasionally in spindle 
shaped cells indicative of fibroblasts (white arrowheads, Figure 1F).
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PPARγ expression in the normal abdominal aorta (AA) of wild-type (WT) mice was sparsely 
detected in VSMCs (Figure 1G-1I). While AAA occurs very rarely in WT mice even after 
infusion of AngII at 1000 ng/kg/min for 4 weeks, we observed in one of the treated mice a 
large bulge of upper suprarenal aorta with a dissecting AAA histology (Figure S3) similar to 
those documented previously.17 PPARγ expression was markedly elevated compared to the 
intact vessels particularly in which the tunica media is torn and bordered by the organizing 
intramural hematoma (Figure 1J and 1K), as well as in the adventitia (Figure 1L). Consistent 
with that in human AAA, PPARγ was mainly expressed in inflammatory cells with a high 
nuclear-cytoplasmic ratio in the luminal surface of vessels and in adventitia. PPARγ was also 
expressed in cells with a spindle shape present in relatively intact medial layers (Figure 1K) 
and in adventitia (Figure 1L), respectively representing VSMCs and fibroblasts. These 
results indicate PPARγ is upregulated in all vascular cell types in atherosclerosis-associated 
AAA in humans as well as in AngII-induced AAA in mice.
Increased Elastic Fiber Fragmentation in PpargC/− Aorta
To examine the functional significance of PPARγ upregulation in AAA development, we 
took advantage of mice with genetic reduction in the Pparg gene expression down to 25% 
normal (PpargC/−) generated by crossing mice having a PPARγ deletion allele (Pparg+/−) 
with mice bearing an allele of c-fos ARE sequence inserted into the PPARγ 3′-UTR region 
(PpargC/+).14 mRNA and protein levels of PPARγ in the descending aorta of PpargC/− mice 
were decreased to 40% and 29% of the WT levels, respectively (Figure S4A and Figure 2A); 
and the reduction was confirmed by the immunohistochemical staining (Figure S4B). In 
addition, the ratio to PPARγ level of Ser82 phosphorylation, which is known to inhibit its 
transactivation, was higher in PpargC/− aorta (Figure S5), suggesting that PPARγ activity 
may be even repressed in PpargC/− aorta. PpargC/− mice have normal plasma cholesterol 
levels, but, consistent with our previous findings,18 they are hypertensive showing higher 
systolic blood pressure (BP) in both light and dark cycles during the telemetric monitoring 
and by a tail-cuff method (Figure 2B and 2C). No gross abnormality in the vascular 
dimensions was present in PpargC/− mice (Table S1 and Figure S4C). However, under light 
microscopic examination, occasional breaks of medial elastic fibers were noted in the closer 
look of the aortas of PpargC/− mice (Figure 2D). Expression of genes coding for elastin 
degradation enzymes MMP-9 and cathepsin S (Ctss) was increased in PpargC/− aorta (Figure 
2E). MMP-9, but not cathepsin S, protein level was elevated in PpargC/− aorta, particularly 
in the medial layer near luminal side (Figure 2A and 2F). We also found a significantly 
increased expression of TNF-α and F4/80 (Adgre1) and a trend toward increased expression 
of IL-1β in PpargC/− aorta (Figure 2G). These results suggest that the elastic fiber 
fragmentation in PpargC/− aorta is associated with increased elastolytic enzymes and 
inflammation in the aorta.
Reduced Production of Elastic Fiber Components in PpargC/− Aorta
Defective elastic fiber formation can also lead to its fragmentation. We therefore examined 
elastic fiber components by immunoblotting in the soluble fraction of aortic lysate, which 
reveals free monomers before assembly into mature fibers. In PpargC/− aorta, tropoelastin 
level was tended to be less and fibulin-5 level was significantly reduced (Figure 2H). The 
levels of collagen type I and fibulin-4 were not different between genotypes. To determine 
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the insoluble fraction of aortic lysate, which directly reflects the functional scaffold of 
mature fibers, we applied liquid chromatography (LC)/mass spectrometer (MS)-based label-
free quantitative proteomic analysis. Among 376 identified proteins from insoluble pellets of 
aortic lysates, 37 proteins were above the identity threshold (Table S2). Many of these 
proteins are vital for ECM organization and elastic fiber assembly in these 37 proteins 
(Table 1). Interestingly, levels of fibulin-5 (0.61), elastin (0.82), fibrillin-1 (0.84) and lysyl 
oxidase homolog 1 (Loxl1; 0.87) were decreased, whereas the levels of collagen alpha-1(I) 
(1.00), alpha-2(I) (1.09), and tubulin alpha-1A (1.00) were not altered in PpargC/− aorta.
At mRNA levels, PpargC/− aortas have significantly reduced expression of Eln, Fbln4, 
Fbln5, and a trend toward decreased Fbn1 expression (Figure 2I). In contrast, expression of 
Eln, Fbln4, Fbln5, and Mmp9 was not significantly changed in Pparg+/− aorta (Figure S6). 
Taken together, these results suggest that severe PPARγ hypomorph itself, without advanced 
stimulations, reduces expression of elastic fiber components, which may also contribute to 
the structural change of mature elastic fibers.
Synergistic Effect of AngII and PPARγ Deficiency on Elastic Fiber Disruption
To test whether Pparg level may mark the aorta for its susceptibility to exogenous insult-
induced injuries, we infused AngII into mice at a moderate dose of 500 ng/kg/min for 4 
weeks. AngII infusion significantly increased systolic BP in both WT and PpargC/− mice by 
approximately 20 mmHg (P<0.001 by two-way ANOVA, Figure 3A and Figure S7) 
compared to untreated mice measured concurrently (Figure 2B). PPARγ genotype had a 
significant effect on elevation of systolic BP (P<0.01) without the interaction between AngII 
and genotype. All AngII-infused mice were fed a cholesterol-enriched western diet, but 
neither atherosclerotic lesions nor aneurysms developed in any of these mice. Elastin 
staining of Pparg+/+ thoracic aorta (TA) and AA showed organized, wavy and consistently 
thickened elastic lamella arrangement. Although Pparg+/− TA and AA maintained relatively 
intact fiber structures, elastic lamellae in both of them became thinner, flattened and lost the 
wavy feature (Figure 3B and 3C). Flattened elastic lamellae were also observed in PpargC/− 
TA and AA. Additionally, while the integrity of elastic lamellae was preserved in PpargC/− 
TA, elastic lamellae in PpargC/− AA exhibited severe destruction with extensive 
inconsistency in thickness and fragmentation into short, thin and fragile segments. 
Quantitation revealed a marked reduction of elastic fiber consistency and an increase of 
breaks in the AA of PpargC/− mice, but the fibers remained normal in Pparg+/− mice (Figure 
3C and Table S3). Thus, our data suggests that 50% reduction in the PPARγ expression can 
still maintain the consistency of elastic fiber in response to a moderate dose of AngII, but 
further reduction will affect structural integrity.
At the molecular level, we found that PPARγ deficiency in combination with AngII infusion 
upregulated expressions of aortic TNF-α, IL-1β, MCP-1 (Cc12) and F4/80 (Adgre1; Figure 
3D), as well as a series of elastin-degradation enzymes, including MMP-7, MMP-9 and 
cathepsin S (Ctss; Figure 3E). Gelatin zymography confirmed elevated MMP-9, but normal 
MMP-2, activity in the AA of AngII-infused PpargC/− mice (Figure 3F). However, MMP-9 
activity remained comparable in the TA of PpargC/− mice. Thus, reduction of PPARγ levels 
renders the aorta susceptible to AngII-induced inflammation and elastic fiber disruption. In 
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AngII-induced mouse AAA, oxidative stress is critical in the regulation of pathogenic 
events.19 Accordingly, we examined expression of pro-oxidant (Cyba, Ncf1, and Ncf2) and 
anti-oxidant enzymes (Sod1 and Cat) in Pparg+/+ and PpargC/− aorta (Figure S8). Analysis 
of results with two-way ANOVA showed that AngII (500 ng/kg/min) has significant effects 
on expression of NADPH oxidase components (Cyba, Ncf1, and Ncf2) and superoxide 
dismutase 1 (Sod1). However, no PPARγ genotype effect was found in the expression of 
Cyba, Ncf1, Ncf2, Sod1, and Cat (catalase). These results suggest that although oxidative 
stress is critical in AngII-induced AAA, accelerated development of AAA seen in PpargC/− 
mice is independent of oxidative stress.
Atypical AAA with Severe SMA Dilation in High-Dose AngII-Infused PpargC/− Mice
A higher dose of AngII (1000 ng/kg/min) infusion for 4 weeks is commonly used for 
aneurysm induction in rodents.20 At this dose, BPs of mice increased further as summarized 
in Figure S7. After 4 weeks of infusion, 1 of 11 Pparg+/+ mice developed bulbous suprarenal 
aneurysm in the left side above the celiac artery branch (Figure S3). In a marked contrast, 8 
of 11 (73%) PpargC/− mice developed dilated suprarenal aneurysms (Figure 4A~4C). The 
aneurysms in PpargC/− mice were, however, atypical and the enlargement was towards the 
ventral side and restricted to a narrow region involving roots of celiac artery (CA) and 
superior mesenteric artery (SMA). Such profound SMA dilatation was not present in the 
aorta of Pparg+/+ mice, and only 1 of 5 Pparg+/− mice developed similar but smaller 
suprarenal aneurysms compared to PpargC/− mice. We monitored the time course of AAA in 
vivo by ultrasound on the mice 2 and 3 weeks post-AngII pump (1000 ng/kg/min) 
implantation. The enlargement of the suprarenal aortic lumen of PpargC/− mice was 
observed at 2 weeks (33%), and continuously increased at 3 weeks (66%). Suprarenal aortic 
lumen diameter was enlarged to 1.64±0.29 mm in PpargC/− mice compared to 1.12±0.05 
mm in Pparg+/+ mice at the 3-week time point (Figure S9).
Histologically, upper portion of the aneurysm (Figure 4D) illustrates the dilatation at the 
branching point of CA in which elastic lamellae of the artery were severely destroyed, 
although their reminiscence clearly demarks the continuity. Intimal thickening was 
characterized by the presence of both VSMCs and inflammatory cells, while adventitial 
hyperplasia was marked with extensive collagen deposition and inflammatory cells (Figure 
4D). Similar abnormalities were observed near the ostium of SMA (Figure 4E). Neither 
signs of truncation of tunica media nor intramural hematoma, such as illustrated in the AAA 
of WT mice in Figure S3, were detected in any of the aneurysms of PpargC/− mice.
Both the arterial lumen size and wall thickness of PpargC/− SMA were grossly increased 
(Figure S10A and S10B). Destruction of medial elastic lamellae (Elastin stain) and 
compensatory deposition of collagen (PS red) were found in the hypertrophic adventitia of 
PpargC/− SMA (Figure S10C). Immunohistochemical staining showed that the smooth 
muscle density (SMactin) was decreased in the medial layer. Interestingly, the dilated 
adventitial region contained predominantly fibroblasts (fibroblast activation protein, FAP) 
(Figure S10D), and showed a dramatic increase of Ki-67-positive signal (Figure S11), 
suggesting that these FAP-positive cells are highly proliferative. Additionally extensive 
macrophage infiltration (MOMA-1) was evident in the outer layer of adventitia (Figure 
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S10D). MMP-9 level was dramatically augmented in the medial to adventitial layer of 
PpargC/− SMA.
No Change of Aneurysm Incidence by MMP Inhibition
To examine whether MMP activity is crucial for the onset of PpargC/− AAA, a broad-
spectrum MMP inhibitor doxycycline (DOX) was administrated in AngII-infused PpargC/− 
mice. DOX (30 mg/kg/day) suppressed aortic MMP-9 activity in PpargC/− mice (Figure 5A). 
However, although DOX treatment attenuated SMA dilation and the diameter of aneurysmal 
dilatations in PpargC/− mice (Figure 5B and 5C), it did not reduce the severity and incidence 
of aneurysm (Figure 5D and 5E; P=0.65 for incidence with Chi square test, P=0.53 even 
after including earlier 8/11). Moreover, DOX treatment did not ameliorate profound 
deterioration and fragile elastic lamellae in the lower AA of PpargC/− mice (Figure 5F), as 
illustrated by the parameters of AA elastic fiber impairments (Figure 5G). These results 
imply that the reduction of fiber component synthesis in PpargC/− aorta plays a key role in 
the initiation of AAA, the pathology of which is significantly enhanced by the increased 
MMP expression associated with inflammation.
PPARγ Antagonism Inhibits Expression of Elastic Fiber Components in Fibroblasts
In PpargC/− aorta, both Eln and Fbln5 expression was reduced even without AngII infusion 
(Figure 2I). Since inflammation has been suggested to affect elastin expression,21 we next 
asked whether PPARγ antagonism or TNF-α elevation inhibits the expression of Eln and 
Fbln5 in aortic smooth muscle cells (ASMCs) and in fibroblasts. Treatments of rat and 
human ASMCs with neither GW9662 nor TNF-α altered the expression of Eln and Fbln5 
(Figure 6A and Figure S12). In a marked contrast, GW9662 significantly suppressed 
expression of Eln and Fbln5 in mouse embryonic fibroblasts (MEFs) (Figure 6B). TNF-α 
significantly suppressed Eln expression, and tended to decrease Fbln5 expression. PPARγ 
knockdown in MEFs reduced expression of both Eln and Fbln5 (Figure 6C), indicating that 
low expression of PPARγ is sufficient to affect the expression of these genes in MEFs. 
Although PPARγ knockdown in human aortic adventitial fibroblasts (HAoAFs) significantly 
reduced expression of FBLN5, it did not alter ELN (Figure 6D). These results suggest that 
PPARγ also has a regulatory role in the expression of fibulin-5 in HAoAFs.
Searching for previously reported chromatin immunoprecipitation (ChIP)-sequencing data,22 
we found three potential PPARγ binding sites in Fbln5, but none in Eln, Fbln4 and Fbn1. 
ChIP-PCR in MEFs showed that PPARγ bound to Fbln5 after treatment of PPARγ agonist 
rosiglitazone, whereas GW9662 abrogates the binding of PPARγ to Fbln5 (Figure 6E), 
indicating that Fbln5 is the direct target of PPARγ. No interaction between PPARγ and Eln 
was identified.
Finally, expression of Mmp9 in rat ASMCs was induced 2 to 3-fold by GW9662 alone, and 
2-fold by TNF-α (Figure 6F; P<0.001 for GW9662 and P<0.01 for TNF-α by two-way 
ANOVA). In contrast, expression of Mmp9 in MEFs was induced 20-fold by TNF-α, but not 
affected by GW9662 (Figure 6G). Taken together, these results demonstrate a direct 
regulatory role of PPARγ in the expression of elastic fiber components, which takes place 
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mainly in fibroblasts. Inflammation further contributes to elastic fiber deterioration in 
PpargC/− aorta via the induction of Mmp9 in the vascular cells.
Discussion
Our study demonstrated the dosage effect of PPARγ on the elastic fiber integrity and that 
adequate PPARγ level is vital for production of elastic fiber components. Qualitatively, 
healthy elastic lamellae show wavy, curl feature and consistency in thickness, whereas poor 
ones become flattened and irregularly thickened. We observed a significant loss of waviness 
and a decrease of fiber thickness in moderate-dose AngII-infused Pparg+/− aortas, despite 
they retained structural integrity without fiber fragmentation. PPARγ expression down to 
25% further induces thickness inconsistency and fiber breaks in PpargC/− aortas. Thus a 
critical amount of PPARγ for maintaining normal elastic waviness is above 50%, whereas 
the threshold level for structure deterioration is between 25% and 50%. These findings 
suggest that loss of elastic fiber waviness is a hallmark of early elastic fiber defect and likely 
attributable to PPARγ insufficiency.
Our LC/MS-based label-free quantitative proteomic analysis of mature elastic fiber 
components in the insoluble ECM fraction showed that fibulin-5, elastin, fibrillin-1 and 
Loxl1, all vital components for elastic fiber assembly, are down-regulated in PpargC/− aorta. 
During elastic fiber assembly, elastin is transported to extracellular space, interacts with 
fibulin-5, and binds to fibrillin-1-formed microfibril scaffold. Lysyl oxidase and its gene 
family, including Loxl1, catalyzes cross-linking of elastin core and microfibril scaffold, 
forming the functional fiber unit.4, 23 Both deficiencies in fibulin-5 and fibrillin-1 cause 
significant fragmentation and disorganization of elastic fibers, whereas Loxl1 deficiency 
leads to imprecise and lower cross-linking of elastic fibers.24 Thus, the reduction of these 
elastic fiber components suggests a direct regulatory role of PPARγ in elastic fiber 
production and assembly.
Infusion of AngII raises BP in mice and a high-dose treatment provides an established 
model of AAA by hypertension.25 Independently, a decreased PPARγ expression in mice 
results in increased BP,18 and PpargC/− mice consistently have 7~18 mmHg higher basal as 
well as both moderate and high-dose AngII-infused BP than WT mice. Thus increased aortic 
wall stress likely contributes to higher AAA incidence of PpargC/− mice treated with a high-
dose AngII. However, high BP may not account for all the aspects of AAA development, 
since PpargC/− mice exhibit loss of elastic fiber integrity even without AngII stimulation. 
PpargC/− mice are more prone to develop aneurysms likely because of a combination of 
increased BP and weak elastic tissues. Supporting this, Kanematsu et al have previously 
shown that co-treatment of AngII and beta-aminopropionitrile, a lysyl oxidase inhibitor, 
markedly increased AAA incidence in mice, suggesting that induced degeneration of elastic 
lamellae enhances the aortic aneurysm incidence caused by hypertension.26
The morphologic features of the AngII-induced AAA in PpargC/− mice, however, differ in 
some specific manners from those typically described on AAA in rodents including those 
described by Kanematsu et al.17, 26 Firstly, no medial rupture was present in PpargC/− aorta, 
despite increased fragmentation of elastic lamellae. Perhaps enhanced fibroblast 
Tai et al. Page 9













proliferation and collagen synthesis in the adventitia acts to protect the wall against rupture 
dampening the stress in the media. Secondly, aortic dilatation in PpargC/− mice appears to be 
initiated near the branching of CA and SMA, and involves the severe dilatation and 
adventitial fibrosis of these arteries. The turbulence of blood flow is likely to be quite high at 
this location since CA and SMA are the major branches of AA. Another consideration is that 
VSMCs of CA and SMA are methothelium origin,27 while aortic VSMCs are dorsal somite 
origin.28 Being composed of two different types of embryonic cells may render the ostia 
more susceptible to injury. Additionally, PPARγ dependency in the cells of two different 
origins may also differ. Finally, a recent report by Davis et al addressed AngII-induced SMA 
aneurysm in mice lacking LRP1 specifically in smooth muscle cells (smLRP1−/−).29 These 
mice showed dilated SMA with severe adventitial and intimal thickenings similar to what we 
observed in PpargC/− mice. The difference was that the dilatation in smLRP1−/− mice 
appears to be restricted to SMA, while the dilatation in PpargC/− mice also involves CA and 
aorta. We note that there is a potential LRP1/PPARγ interaction,30 and the LRP1 gene has a 
PPARγ binding site.31
Immediate backup by de novo generation of components for fiber production and assembly 
is a critical process in forming a functional fiber unit during AAA development. However, 
overwhelming degradation and massive destruction of elastic fiber can mask the underlying 
defects of elastic fiber production. For instance, the upregulation of elastolytic MMP-9 and 
cathepsin S was profound in AngII infused-PpargC/− aortas. DOX administration prior to 
AAA induction has been shown to reduce the incidence and dilation of AAA efficiently 
through inhibiting MMP in elastase-induced wild-type or hypercholesterolemic AngII-
infused mice.32, 33 However, DOX did not regress or prevent the progression of established 
AngII-induced AAAs.34 Our study showed that DOX pre-treatment attenuated aneurysmal 
dilation, but it did not reduce the incidence of AAA in PpargC/− mice. Importantly, DOX did 
not ameliorate profound deterioration of elastic lamellae in PpargC/− AA. Thus, attenuation 
of AAA incidence in the aorta by DOX appears to require intact elastogenesis machinery, 
whereas it is not effective in the elastogenesis-defective aorta. Although proteinases other 
than MMPs mediating this profound destruction cannot be excluded, the negative effect of 
DOX on PpargC/− AAA is likely due to pre-exited defects in elastic fiber integrity and 
elastogenesis. The controversial effects of DOX in attenuating AAA growth in clinical 
studies35, 36 could also be related to the individual variations in elastogenesis machinery.
The role of VSMCs in vascular wall integrity and the significance of VSMC loss in AAA 
development have been well documented.37 A loss of PPARγ in VSMCs has been shown to 
promote aortic dilatation and elastin degradation in CaCl2-induced AAA, indicating a 
critical role of PPARγ in attenuation of inflammation and elastic fiber degradation in 
VSMCs during AAA. In contrast, fibroblast, another actively participant in the structural 
remodeling of AAA, has not gained much attention to date. Despite that the lack of cell 
selectivity in PpargC/− model is a limitation in dissecting the cell-specific role of PPARγ 
level, our current results strongly suggest an important role of fibroblast PPARγ in AAA 
development. For example, we found that one of the predominant cell types in both human 
and mouse AAA lesions expressing high-level of PPARγ had fibroblast-like features. In 
addition, a fibroblast marker, FAP, was substantially elevated in the dilated adventitia of 
PpargC/− aneurysm. FAP is expressed by activated (highly proliferative) fibroblasts in 
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epithelial tumor stroma, arthritis, and wound healing.38 Although we cannot determine the 
origin of these FAP-positive cells, a dramatic increase of Ki-67-positive signal in the dilated 
adventitia containing predominantly FAP-positive cells at least suggest that they are highly 
proliferative (Figure S11). Taken together, our observations that PpargC/− fibroblasts are 
actively contributing to collagen deposition and enlargement of aneurysm adventitia suggest 
that the regulatory role of PPARγ in fibroblasts has a direct impact on the overall vessel 
integrity in AAA.
Our in vitro study showed that PPARγ inhibition in MEFs, but not in VSMCs, dramatically 
attenuated expression of Eln and Fbln5. ChIP analysis in MEFs further confirmed a direct 
interaction between PPARγ and Fbln5. This PPARγ-interacting region is located in the 
introns of Fbln5, and a similar intronic regulation by PPARγ has been reported.39 FBLN5 
expression was also reduced in the PPARγ-knockdowned HAoAFs, albeit to a lesser degree. 
It is worth noting that the effects of PPARγ knockdown on expression of Eln differ between 
MEFs and HAoAFs. Although species variation cannot be ignored, the response of 
embryonic fibroblasts may differ from that of adult primary vascular fibroblasts. 
Elastogenesis is restricted to a short period of embryonic and neonatal stages, and by the 
postnatal day 14, right after the deposition of elastin and assembly into extracellular fibers, 
the synthesis and production of elastic fibers are shut down rapidly. However, in the 
pathological condition, like AAA, adventitial fibroblasts encounter numerous stimulants, 
such as AngII and inflammatory cytokines. These stimulated fibroblasts may have a distinct 
regulatory program on elastic fiber components from fully differentiated, quiescent cells. 
Since we did not detect a direct interaction between PPARγ and Eln, the down-regulation of 
Eln by PPARγ antagonism in MEF may be mediated through an indirect mechanism. While 
the detailed regulation of Fbln5 and Eln expression by PPARγ requires further investigation, 
PPARγ may be considered as a potential target for regulating elastogenesis in AAA therapy.
Perspectives
Our study of mice with varying Pparg expression indicates that quantitative variants causing 
decreased Pparg expression are a risk factor for AAA. Without advanced stimulations, more 
than 25% of normal PPARγ level is necessary to maintain elastic fiber components in the 
aorta and fibroblasts are vital for this action. Thus, this study highlights the importance of 
adequate PPARγ level in AAA treatment through orchestrating proper elastogenesis and 
preserving elastic fiber integrity. Importantly, new pharmacological interventions targeting 
PPARγ should be revisited in AAA therapy.
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The critical amount of PPARγ for maintaining normal elastic waviness is above 50%, 
whereas the threshold level for elastic fiber breakdown is between 25% and 50%. 
Waviness loss of elastic fibers, which occurs early before the aneurysm develops, is 
attributable to PPARγ haploinsufficiency in conjunction with a moderate environmental 
insult.
PPARγ expression down to 25% (PpargC/−) in the aorta down-regulates the expression of 
vital elastic fiber components, elastin and fibulin-5. The regulatory role of PPARγ in 
elastogenesis takes place in fibroblasts by binding the genomic sequence of Fbln5.
What Is Relevant?
Our study highlights PPARγ as a vital regulator in AAA development. Thus, 
determination of PPARγ level/activity would be important for patients at a higher risk for 
developing AAA. Moreover, pharmacological intervention targeting PPARγ level/activity 
would be beneficial to preserve elastic fiber integrity during AAA initiation and 
development.
Summary
Our study underscores the importance of adequate PPARγ level in maintaining elastic 
fiber integrity though orchestrating proper expression of elastin and fibulin-5, further 
preventing from AAA development.
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Expression of PPARγ in human and mouse AAA. A–F, Immunohistochemical staining of 
PPARγ in normal human aorta (A–C) and human AAA (D–F). Filled arrows in (C) and (F) 
indicate cells resembling inflammatory cells. Open arrows in (E) resemble VSMCs. Open 
arrowheads in (F) indicate elongated endothelial cells or fibroblasts in or near microvessels. 
Int: intima; Med: media; Adv: adventitia. G–I, Normal AA of WT mice. Magnification of 
the black square in (G) is shown in (H) and (I). PPARγ expression is detected in some 
VSMCs of WT mice. J–L, AngII-induced dissecting AAA in WT mice. Section (J) shows 
prominent PPARγ expression in the inflammatory cells (filled arrows) of the luminal surface 
(K) and adventitia (L) as well as in VSMCs (open arrow in K), and fibroblasts (open 
arrowheads in L). Magnification of the black square is shown in the indicated picture. Scale 
bars in (B, C, E, F, H, I, K, and L) are 100 μm and in (A, D, G and J) are 1000 μm.
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Elastic fiber fragmentation and expression of elastic fiber components in PpargC/− aorta. A, 
Immunoblot of PPARγ, cathepsin S and MMP-9 in the aorta (N=3 in each group). The 
relative intensities of the bands are indicated by densitometric quantification with WT. B, 
Tail-cuff and (C) telemetry systolic BP measurement in Pparg+/+ and PpargC/− mice. N=6 in 
(B) and 5 in (C). D, Representative images of the elastic network and quantification of 
elastic fiber breaks in the longitudinal section of aorta. Arrows indicate breaks in the elastic 
fiber. Numbers of breaks of elastic layers per 10,000 μm2 are shown in the right (N=5 in 
each group). E, mRNA levels of elastolytic enzymes in PpargC/− aorta are shown relative to 
the mean levels in Pparg+/+ aorta as 1.0 (+/+ = 7, C/− = 6). F, Immunohistochemical staining 
of MMP-9 in the longitudinal section of aorta. Lu: lumen. G, mRNA levels of inflammatory 
cytokines and macrophage markers relative to the mean levels in Pparg+/+ aorta as 1.0 (+/+ = 
20, C/− = 16). H, Immunoblot and quantification of ECM components in the soluble fraction 
of aortic lysates (N=3 in each group) I, mRNA levels of ECM components (N=12–14 in 
each group).*P<0.05, **P<0.01, and ***P<0.001. Scale bars in (D) are 100 μm and in (F) 
are 50 μm.
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Effects of moderate-dose AngII (500 ng/kg/min) infusion. A, Tail-cuff systolic BP 
measurement in AngII-infused Pparg+/+ and PpargC/− mice (N=9 in each group). B, 
Representative images of the elastic network in the TA and AA. Scale bars are 100 μm. C, 
Parameters of elastic fiber integrity, including thickness, waviness, consistency, and breaks 
of elastic lamellae, in the AA (+/+ = 5, +/− = 3, C/− = 7). *P<0.05, **P<0.01, and 
***P<0.001 by one-way ANOVA with Tukey HSD test. D and E, mRNA levels for 
inflammatory mediators and for elastolytic proteases, respectively, in the aorta. Data are 
expressed relative to the mean in Pparg+/+ aorta as 1.0 (N=5 in each group). *P<0.05 and 
**P<0.01 by Student’s t-test. F, Gelatin zymography of protein lysate from TA and AA.
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Suprarenal aneurysms in high-dose AngII (1000 ng/kg/min) infused PpargC/− mice. A, 
Representative photographs of the aorta. White arrow indicates aneurysm. B, Magnified 
view of AA region. CA: celiac artery. SMA: superior mesenteric artery. RR: right renal 
artery. LR: left renal artery. C, Maximal external aortic diameter and percentage of severity 
grade in AngII-infused mice (+/+ = 6, +/− = 5, C/− = 6). D and E, Elastin, collagen (PS red) 
staining and immunohistochemistry staining for SMactin of AA. ***P<0.001 by one-way 
ANOVA with Tukey HSD test. Scale bars in (D) are 200 μm and in (E) are 1000 μm.
Tai et al. Page 19














Effects of MMP inhibition on AngII-infused PpargC/− aneurysm. A, Gelatin zymography of 
protein lysates from AA. B, Representative photographs of the AAA. C, Maximal aortic 
diameter, (D) percentage of severity grade and (E) incidence of AAA in AngII-infused 
PpargC/− mice. F, Representative images of the elastic network and (G) parameters of elastic 
fiber integrity in AA (N=5–6 in each group). Locations of sections in (F) were indicated by 
dash lines in (B). Scale bars are 200 μm in upper panels and 100 μm in lower panels of (F). 
*P<0.05.
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Effects of PPARγ antagonism on expression of elastic fiber components. Expression of Eln 
and Fbln5 after treatment with GW9662 or TNF-α in rat ASMCs (A, gray bars) and MEFs 
(B, white bars). N=3 in each group. C, Expression of Pparg, Eln and Fbln5 in MEFs and (D) 
HAoAFs treated with scrambled siRNA or siRNA against PPARγ (siPPARγ). N=7–8 in each 
group. E, ChIP assay in MEFs. Sequences containing the potential PPARγ binding sites in 
Eln and Fbln5 were amplified by real-time PCR. Rosi: rosiglitazone. Expression of Mmp9 
after treatment with GW9662, AngII, or TNF-α in rat ASMCs (F) and MEFs (G). *P<0.05, 
**P<0.01, and ***P<0.001 in (A–B and E–G) by one-way ANOVA with Tukey HSD test. 
*P<0.05 in (C and D) by Student’s t-test.
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Table 1
Proteins involved in elastic fiber assembly and ECM organization.
Protein description Ratio (C/− / +/+) Quantifiable peptides Identified peptides Biological process
Fibulin-5 0.61 7 9 Elastic fiber assembly
Periostin 0.72 8 23 ECM organization
Elastin 0.82 7 11 Elastic fiber assembly
Collagen alpha-2(VI) chain 0.84 8 21 ECM organization
Fibrillin-1 0.84 7 40 Elastic fiber assembly
Decorin 0.85 3 8 ECM organization
Lysyl oxidase homolog 1 0.87 7 15 Elastic fiber assembly
Fibronectin 0.90 12 35 ECM organization
Basement membrane-specific heparan sulfate 
proteoglycan core protein 0.92 8 37 ECM organization
Collagen alpha-1(VI) chain 0.95 4 16 ECM organization
Collagen alpha-1(I) chain 1.00 6 8 ECM organization
Collagen alpha-2(I) chain 1.09 4 7 ECM organization
Identified peptides: number of peptides with MASCOT individual ion score above 20.
Quantifiable peptides: number of Identified peptides with quantitation ratio (C/− versus +/+).
N=5 in each group.
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